Literature DB >> 32460580

TGFβ (Transforming Growth Factor-Beta)-Activated Kinase 1 Regulates Arteriovenous Fistula Maturation.

Haidi Hu1,2,3, Shin-Rong Lee2,3, Hualong Bai2,3, Jianming Guo2,3, Takuya Hashimoto2,3, Toshihiko Isaji2,3, Xiangjiang Guo2,3, Tun Wang2,3, Katharine Wolf2,3, Shirley Liu2,3, Shun Ono2,3, Bogdan Yatsula2,3, Alan Dardik2,3,4.   

Abstract

OBJECTIVE: Arteriovenous fistulae (AVF) are the optimal conduit for hemodialysis access but have high rates of primary maturation failure. Successful AVF maturation requires wall thickening with deposition of ECM (extracellular matrix) including collagen and fibronectin, as well as lumen dilation. TAK1 (TGFβ [transforming growth factor-beta]-activated kinase 1) is a mediator of noncanonical TGFβ signaling and plays crucial roles in regulation of ECM production and deposition; therefore, we hypothesized that TAK1 regulates wall thickening and lumen dilation during AVF maturation. Approach and
Results: In both human and mouse AVF, immunoreactivity of TAK1, JNK (c-Jun N-terminal kinase), p38, collagen 1, and fibronectin was significantly increased compared with control veins. Manipulation of TAK1 in vivo altered AVF wall thickening and luminal diameter; reduced TAK1 function was associated with reduced thickness and smaller diameter, whereas activation of TAK1 function was associated with increased thickness and larger diameter. Arterial magnitudes of laminar shear stress (20 dyne/cm2) activated noncanonical TGFβ signaling including TAK1 phosphorylation in mouse endothelial cells.
CONCLUSIONS: TAK1 is increased in AVF, and TAK1 manipulation in a mouse AVF model regulates AVF thickness and diameter. Targeting noncanonical TGFβ signaling such as TAK1 might be a novel therapeutic approach to improve AVF maturation.

Entities:  

Keywords:  arteriovenous fistula; collagen; endothelial cells; humans; mice; tak1; transforming growth factor beta

Mesh:

Substances:

Year:  2020        PMID: 32460580      PMCID: PMC7316601          DOI: 10.1161/ATVBAHA.119.313848

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  60 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

2.  Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates.

Authors:  Monica Y Lee; Amelia K Luciano; Eric Ackah; Juan Rodriguez-Vita; Tara A Bancroft; Anne Eichmann; Michael Simons; Themis R Kyriakides; Manuel Morales-Ruiz; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

3.  Predictors of adequacy of arteriovenous fistulas in hemodialysis patients.

Authors:  P E Miller; A Tolwani; C P Luscy; M H Deierhoi; R Bailey; D T Redden; M Allon
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

4.  Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

Authors:  Laura M Dember; Gerald J Beck; Michael Allon; James A Delmez; Bradley S Dixon; Arthur Greenberg; Jonathan Himmelfarb; Miguel A Vazquez; Jennifer J Gassman; Tom Greene; Milena K Radeva; Gregory L Braden; T Alp Ikizler; Michael V Rocco; Ingemar J Davidson; James S Kaufman; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  JAMA       Date:  2008-05-14       Impact factor: 56.272

Review 5.  Cell type-specific function of TAK1 in innate immune signaling.

Authors:  Adebusola A Ajibade; Helen Y Wang; Rong-Fu Wang
Journal:  Trends Immunol       Date:  2013-05-07       Impact factor: 16.687

6.  TAK1 plays a major role in growth factor-induced phenotypic modulation of airway smooth muscle.

Authors:  Tonio Pera; Riham Sami; Johan Zaagsma; Herman Meurs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 6.011

7.  The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.

Authors:  Yan-Xiao Ji; Peng Zhang; Xiao-Jing Zhang; Yi-Chao Zhao; Ke-Qiong Deng; Xi Jiang; Pi-Xiao Wang; Zan Huang; Hongliang Li
Journal:  Nat Commun       Date:  2016-06-01       Impact factor: 14.919

8.  Suppression of TAK1 pathway by shear stress counteracts the inflammatory endothelial cell phenotype induced by oxidative stress and TGF-β1.

Authors:  Ee Soo Lee; Llorenç Solé Boldo; Bernadette O Fernandez; Martin Feelisch; Martin C Harmsen
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

9.  Eph-B4 regulates adaptive venous remodeling to improve arteriovenous fistula patency.

Authors:  Clinton D Protack; Trenton R Foster; Takuya Hashimoto; Kota Yamamoto; Monica Y Lee; Jan R Kraehling; Hualong Bai; Haidi Hu; Toshihiko Isaji; Jeans M Santana; Mo Wang; William C Sessa; Alan Dardik
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

10.  Adventitial transduction of lentivirus-shRNA-VEGF-A in arteriovenous fistula reduces venous stenosis formation.

Authors:  Binxia Yang; Rajiv Janardhanan; Pawan Vohra; Eddie L Greene; Santanu Bhattacharya; Sarah Withers; Bhaskar Roy; Evelyn C Nieves Torres; Jaywant Mandrekar; Edward B Leof; Debabrata Mukhopadhyay; Sanjay Misra
Journal:  Kidney Int       Date:  2013-08-07       Impact factor: 10.612

View more
  6 in total

1.  Heme Oxygenase 1/Peroxisome Proliferator-Activated Receptor Gamma Pathway Protects Intimal Hyperplasia and Mitigates Arteriovenous Fistula Dysfunction by Regulating Oxidative Stress and Inflammatory Response.

Authors:  Tingfei Xie; Yunpeng Xu; Lecai Ji; Xiaolu Sui; Aisha Zhang; Yanzi Zhang; Jihong Chen
Journal:  Cardiovasc Ther       Date:  2022-06-12       Impact factor: 3.368

2.  Nitric oxide releasing nanomatrix gel treatment inhibits venous intimal hyperplasia and improves vascular remodeling in a rodent arteriovenous fistula.

Authors:  Maheshika Somarathna; Patrick Tj Hwang; Reid C Millican; Grant C Alexander; Tatyana Isayeva-Waldrop; Jennifer A Sherwood; Brigitta C Brott; Isabelle Falzon; Hannah Northrup; Yan-Ting Shiu; Chris J Stubben; John Totenhagen; Ho-Wook Jun; Timmy Lee
Journal:  Biomaterials       Date:  2021-11-18       Impact factor: 15.304

3.  Endothelial Cell TGF-β (Transforming Growth Factor-Beta) Signaling Regulates Venous Adaptive Remodeling to Improve Arteriovenous Fistula Patency.

Authors:  Ryosuke Taniguchi; Yuichi Ohashi; Jung Seok Lee; Haidi Hu; Luis Gonzalez; Weichang Zhang; John Langford; Yutaka Matsubara; Bogdan Yatsula; George Tellides; Tarek M Fahmy; Katsuyuki Hoshina; Alan Dardik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-05-05       Impact factor: 10.514

4.  Activation of EphrinB2 Signaling Promotes Adaptive Venous Remodeling in Murine Arteriovenous Fistulae.

Authors:  Tun Wang; Jia Liu; Haiyang Liu; Shin-Rong Lee; Luis Gonzalez; Jolanta Gorecka; Chang Shu; Alan Dardik
Journal:  J Surg Res       Date:  2020-10-07       Impact factor: 2.417

5.  Inhibition of T-Cells by Cyclosporine A Reduces Macrophage Accumulation to Regulate Venous Adaptive Remodeling and Increase Arteriovenous Fistula Maturation.

Authors:  Yutaka Matsubara (松原裕); Gathe Kiwan; Jia Liu (刘佳); Luis Gonzalez; John Langford; Mingjie Gao (高明杰); Xixiang Gao (高喜翔); Ryosuke Taniguchi (谷口良輔); Bogdan Yatsula; Tadashi Furuyama (古山正); Takuya Matsumoto (松本拓也); Kimihiro Komori (古森公浩); Alan Dardik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-21       Impact factor: 10.514

Review 6.  Sex Differences in Inflammation During Venous Remodeling of Arteriovenous Fistulae.

Authors:  Shin Mei Chan; Gabe Weininger; John Langford; Daniel Jane-Wit; Alan Dardik
Journal:  Front Cardiovasc Med       Date:  2021-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.